Document is current
Any future updates will be listed below
-
Authors
Zhang, Zhichang
Wang, Weicheng
Xu, Peng
Cui, Quanjun
Yang, Xinlin
Hassan, Ameer E.
- License Information
-
More Information
Article History
Received: 6 November 2023
Accepted: 9 May 2024
First Online: 14 May 2024
Competing interests
: All authors except A.E.H. declare no conflict of interest. A.E.H. has filed provisional patents for NAG as an antiviral treatment band for BNAG1 and BNAG 2 as an antiviral and anti-inflammatory treatment. A.E.H. reports consulting for Medtronic, Microvention, Stryker, Penumbra, Cerenovus, Genentech, GE Healthcare, Scientia, Balt, Viz.ai, Insera therapeutics, Proximie, NovaSignal, and Vesalio; acting as principal investigator for the COMPLETE study funded by Penumbra, and LVO SYNCHRONISE funded by Viz.ai; participating in the steering committee/publication committee member for SELECT, DAWN, SELECT 2, EXPEDITE II, EMBOLISE, and CLEAR trials.
